A Comparative, Randomized Trial of Concentration-Controlled Sirolimus Combined With Reduced-Dose Tacrolimus or Standard-Dose Tacrolimus in Renal Allograft Recipients-Reference-Cited by-同舟云学术

A Comparative, Randomized Trial of Concentration-Controlled Sirolimus Combined With Reduced-Dose Tacrolimus or Standard-Dose Tacrolimus in Renal Allograft Recipients

Published:2013-07 Issue:6 Volume:45 Page:2133-2140
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Bechstein W.O.,Paczek L.,Wramner L.,Squifflet J.-P.,Zygmunt A.J.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference40 articles.

1. The natural history of chronic allograft nephropathy;Nankivell;N Engl J Med,2003

2. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy;Bennett;Kidney Int,1996

3. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group;Solez;Transplantation,1998

4. Histopathology of calcineurin inhibitor-induced nephrotoxicity;Davies;Transplantation,2000

5. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations;Andoh;Semin Nephrol,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study;PLOS ONE;2024-01-02

2. Comparative Safety and Efficacy of Immunosuppressive Regimens Post-Kidney Transplant: A Systematic Review;Cureus;2023-08-22

3. Calcineurin Inhibitors Nephrotoxicity Prevention Strategies With Stress on Belatacept-Based Rescue Immunotherapy: A Review of the Current Evidence;Transplantation Proceedings;2021-06

4. Combination of calcineurin and mTOR inhibitors in kidney transplantation: a propensity score analysis based on current clinical practice;Journal of Nephrology;2019-12-18

5. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients;Cochrane Database of Systematic Reviews;2019-12-16